The Clorox Company $CLX Shares Sold by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S reduced its stake in The Clorox Company (NYSE:CLX) by 15.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 91,192 shares of the company’s stock after selling 16,734 shares during the period. BI Asset Management Fondsmaeglerselskab A S owned approximately 0.07% of Clorox worth $11,244,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after buying an additional 514 shares during the period. Woodline Partners LP raised its stake in shares of Clorox by 253.7% during the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after purchasing an additional 7,465 shares during the period. Ameritas Advisory Services LLC acquired a new position in shares of Clorox during the second quarter worth $48,000. Belpointe Asset Management LLC boosted its stake in shares of Clorox by 10.5% in the second quarter. Belpointe Asset Management LLC now owns 3,516 shares of the company’s stock valued at $422,000 after purchasing an additional 335 shares during the period. Finally, Shell Asset Management Co. boosted its stake in shares of Clorox by 94.8% in the second quarter. Shell Asset Management Co. now owns 16,079 shares of the company’s stock valued at $1,931,000 after purchasing an additional 7,824 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.1%

NYSE:CLX opened at $117.59 on Friday. The company has a quick ratio of 0.50, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The business’s 50 day moving average is $105.58 and its two-hundred day moving average is $114.01. The Clorox Company has a 52 week low of $96.66 and a 52 week high of $159.04. The company has a market cap of $14.22 billion, a PE ratio of 19.21, a P/E/G ratio of 0.57 and a beta of 0.59.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the firm posted $1.55 earnings per share. Clorox’s revenue was down .8% compared to the same quarter last year. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.2%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio is currently 81.05%.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target to $136 (equal-weight), signaling meaningful upside versus the current level and providing buy-side support. Article Title
• Positive Sentiment: Jefferies kept a Buy rating and a high target (~$151), reinforcing a bullish view on longer-term recovery and giving investors a favorable risk/reward case. Article Title
• Neutral Sentiment: Clorox reiterated its 2026 outlook despite mixed Q2 results, which limits downside if management delivers on guidance and execution. Article Title
• Neutral Sentiment: Clorox will present at the CAGNY conference (Feb. 19), offering investors a near-term opportunity for management to outline strategy and provide more color on ERP integration and potential M&A (GOJO). Article Title
• Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates ($1.39 vs. $1.43), organic sales fell year-over-year, and margin pressure from higher costs and ERP-related expenses was highlighted — primary near-term negative catalyst. Article Title
• Negative Sentiment: Evercore cut its target sharply to $115 and kept an Underperform rating, increasing sell-side pressure and signalling concerns about near-term profitability. Article Title
• Negative Sentiment: Deutsche Bank trimmed its target to $112 (hold), and TD Cowen’s $111 target (hold) also implies downside — several shops are skeptical on margins and the ERP/integration timeline. Article Title Article Title
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 miss even while nudging its target to $112 — a reminder margins and execution (inventory reset, ERP) are the biggest risks near term. Article Title

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Morgan Stanley boosted their price objective on shares of Clorox from $125.00 to $136.00 and gave the stock an “equal weight” rating in a report on Thursday. Jefferies Financial Group dropped their target price on Clorox from $152.00 to $151.00 and set a “buy” rating on the stock in a research report on Wednesday. Evercore ISI reduced their price target on Clorox from $132.00 to $115.00 and set an “underperform” rating for the company in a report on Wednesday. Citigroup raised their price objective on Clorox from $109.00 to $115.00 and gave the company a “neutral” rating in a research note on Wednesday. Finally, UBS Group upped their target price on Clorox from $115.00 to $121.00 and gave the company a “neutral” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating, ten have given a Hold rating and five have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and an average target price of $117.93.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were purchased at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares in the company, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 0.63% of the stock is currently owned by corporate insiders.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.